Back to search results

Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery

Abroad (travel likely)RecruitingPHASE2

Conditions

Triple Negative Breast Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • CHU Amiens Picardie_Site Sud, Amiens, France

    Contact: Study coordinator (Aurélie MOREIRA, MD) · Moreira.Aurelie@chu-amiens.fr
    Contact: Principal Investigator (Aurélie MOREIRA, MD)

  • Institut Sainte Catherine, Avignon, France

    Contact: Study coordinator (Julien GRENIER) · j.grenier@isc84.org
    Contact: Principal Investigator (Julien GRENIER, MD)

  • Centre Hospitalier de la Côte Basque, Bayonne, France

    Contact: Study coordinator (Thomas GRELLETY, MD) · tgrellety@ch-cotebasque.fr · +335 59 44 37 62
    Contact: Principal Investigator (Thomas GRELLETY, MD)

  • CHU Jean Minoz, Besançon, France

    Contact: Study coordinator (Laura MANSI, MD) · lmansi@chu-besancon.fr
    Contact: Principal Investigator (Laura MANSI, MD)

  • Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France

    Contact: Study coordinator (Nadine DOHOLLOU, MD) · n.dohollou@gor.bordeauxnord.com
    Contact: Principal Investigator (Nadine DOHOLLOU, MD)

  • Centre François Baclesse, Caen, France

    Contact: Study coordinator (George EMILE, MD) · g.emile@baclesse.unicancer.fr
    Contact: Principal Investigator (Georges EMILE, MD)

  • Centre Georges-François Leclerc, Dijon, France

    Contact: Study coordinator (Sylvain LADOIRE, MD) · sladoire@cgfl.fr
    Contact: Principal Investigator (Sylvain LADOIRE, MD)

  • CHD Vendee, La Roche-sur-Yon, France

    Contact: Study coordinator (Camille GOISLARD DE MONSABERT, MD) · camille.goislard-demonsabert@ght85.fr · +332 51 44 61 73
    Contact: Principal Investigator (Camille GOISLARD DE MONSABERT, MD)

  • Centre Oscar Lambret, Lille, France

    Contact: Study coordinator (Claire CHEYMOL, MD) · c-cheymol@o-lambret.fr
    Contact: Principal Investigator (Claire CHEYMOL, MD)

  • Centre Léon Bérard, Lyon, France

    Contact: Study coordinator (Olivier TREDAN, MD) · olivier.tredan@lyon.unicancer.fr
    Contact: Principal Investigator (Olivier TREDAN, MD)

  • Institut Paoli-Calmettes, Marseille, France

    Contact: Study coordinator (Alexandre DE NONNEVILLE, MD) · denonnevillea@ipc.unicancer.fr
    Contact: Principal Investigator (Alexandre DE NONNEVILLE, MD)

  • Institut Curie, Paris, France

    Contact: Study coordinator (Delphine LOIRAT, MD) · delphine.loirat@curie.fr · +331 56 24 55 00
    Contact: Principal Investigator (Delphine LOIRAT, MD)

  • Clinique de La Croix du sud, Quint-Fonsegrives, France

    Contact: Study coordinator (Francesco RICCI, MD) · Ricci.onco@outlook.com · +335 32 02 72 44
    Contact: Principal Investigator (Francesco RICCI, MD)

  • Institut Godinot, Reims, France

    Contact: Study coordinator (Christelle JOUANNAUD, MD) · christelle.jouannaud@reims.unicancer.fr · +333 26 50 43 83
    Contact: Principal Investigator (Christelle JOUANNAUD, MD)

  • Institut Curie, Saint-Cloud, France

    Contact: Study coordinator (LOIRAT, MD) · delphine.loirat@curie.fr · +33147 11 15 15
    Contact: Principal Investigator (Delphine LOIRAT, MD)

  • Clinique Mutualiste de l'Estuaire, Saint-Nazaire, France

    Contact: Study coordinator (Tifenne L'HARIDON, MD) · tifenn.lharidon@hospigrandouest.fr
    Contact: Principal Investigator (Tiffen L'HARIDON, MD)

  • Centre Paul Strauss, Strasbourg, France

    Contact: Study coordinator (Thierry PETIT, MD) · t.petit@icans.eu
    Contact: Principal Investigator (Thierry PETIT, MD)

  • Institut Claudius Regaud, IUCT Oncopole, Toulouse, France

    Contact: Study coordinator (MD) · Dalenc.Florence@iuct-oncopole.fr · +335 31 15 51 22
    Contact: Principal Investigator (Florence DALENC, MD)

  • CHU Bretonneau, Tours, France

    Contact: Study coordinator (Marie-Agnès BY, MD) · MA.BY@chu-tours.fr
    Contact: Principal Investigator (Marie-Agnès BY, MD)

  • Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France

    Contact: Study coordinator (Anne KIEFFER, MD) · a.kieffer@nancy.unicancer.fr · +333 83 59 85 64
    Contact: Principal Investigator (Anne KIEFFER, MD)
Study leads

  • Delphine LOIRAT, MD PhD

    Principal Investigator

    Institut Curie Paris

  • Jean-Yves PIERGA, MD

    Principal Investigator

    Institut Curie Paris

View source on ClinicalTrials.gov(opens in a new tab)